Iovance Biotherapeutics (IOVA) had the highest return on March 6 by a mid-cap US stock, returning 16.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Iovance Biotherapeutics (IOVA) | 3/6/2026 | 16.06% |
GDS (GDS) | 3/6/2026 | 8.91% |
Sellas Life Sciences (SLS) | 3/6/2026 | 8.43% |
Dianthus Therapeutics (DNTH) | 3/6/2026 | 8.38% |
John Wiley & Sons (WLY) | 3/6/2026 | 7.98% |
Beam Therapeutics (BEAM) | 3/6/2026 | 7.89% |
AeroVironment (AVAV) | 3/6/2026 | 7.07% |
Viking Therapeutics (VKTX) | 3/6/2026 | 6.77% |
Lionsgate Studios (LION) | 3/6/2026 | 6.71% |
Ringcentral (RNG) | 3/6/2026 | 6.6% |
Legend Biotech (LEGN) | 3/6/2026 | 6.51% |
Insperity (NSP) | 3/6/2026 | 6.41% |
Septerna, Inc Common Stock (SEPN) | 3/6/2026 | 6.4% |
Relay Therapeutics (RLAY) | 3/6/2026 | 6.23% |
ChronoScale (CHRN) | 3/6/2026 | 5.96% |
Planet Labs PBC (PL) | 3/6/2026 | 5.82% |
UFP Technologies (UFPT) | 3/6/2026 | 5.39% |
ServiceTitan, Inc Class A Common Stock (TTAN) | 3/6/2026 | 5.12% |
IES (IESC) | 3/6/2026 | 5.11% |
Vaxcyte (PCVX) | 3/6/2026 | 4.92% |
OceanaGold (OGC) | 3/6/2026 | 4.85% |
Xpeng (XPEV) | 3/6/2026 | 4.84% |
Murphy USA (MUSA) | 3/6/2026 | 4.84% |
Progyny (PGNY) | 3/6/2026 | 4.75% |
B2Gold (BTG) | 3/6/2026 | 4.72% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.